Phase I Hematology/Oncology Clinical Investigator (Assistant/Associate Professor)

Position Details

Position Information

Recruitment/Posting Title Phase I Hematology/Oncology Clinical Investigator (Assistant/Associate Professor) Department CINJ - Medical Solid Tumor Salary Details A minimum of $283,010 for assistant professor or $344,678, for associate professor. Offer Information

The final salary offer may be determined by several factors, including, but not limited to, the candidate's qualifications, experience, and expertise, and availability of department or grant funds to support the position. We also take into consideration market benchmarks, if and when appropriate, and internal equity to ensure fair compensation relative to the university's broader compensation structure. We are committed to offering competitive and flexible compensation packages to attract and retain top talent.

Benefits

Rutgers provides a comprehensive benefits package to eligible employees. The specific benefits vary based on the position and may include:

• Medical, prescription drug, and dental coverage
• Paid vacation, holidays, and various leave programs
• Competitive retirement benefits, including defined contribution plans and voluntary tax-deferred savings options
• Employee and dependent educational benefits (when applicable)
• Life insurance coverage
• Employee discount programs

Posting Summary

Rutgers Cancer Institute and RWJBarnabas Health seek an academically oriented medical oncologist or hematologist to join and help grow our Phase 1 Experimental Therapeutics Program. The successful candidate will play a key role in the design, conduct, and expansion of early-phase clinical trials while increasing patient access to innovative cancer therapies at New Jersey's only NCI-Designated Comprehensive Cancer Center and across the RWJBarnabas Health system.

Candidates with an interest in Phase I trial development and translational research are encouraged to apply. Disease specialization is flexible and will be aligned with the successful candidate's clinical and research interests with opportunities to maintain and grow a disease-specific practice while participating in a robust early-phase therapeutics program.

Opportunity Highlights

• Conduct and develop early-phase clinical trials, including first-in-human, targeted therapy, immuno-oncology, and combination studies.
• Ensure protocol adherence and compliance with ICH-GCP, FDA regulations (21 CFR), IRB requirements, and institutional SOPs.
• Author and review protocols, informed consent documents, abstracts, and manuscripts.
• Interpret and integrate pharmacokinetic (PK), pharmacodynamic (PD), and correlative/biomarker data into clinical decision-making.
• Collaborate with sponsors, CROs, translational scientists, pharmacists, and research coordinators to advance study conduct and portfolio growth.
• Contribute to feasibility assessments, site selection, for new early-phase trials and expand access throughout the RWJBarnabas Health network.
• Mentor students, housestaff, fellows, and junior faculty, and research staff.
• Startup support and research infrastructure will be provided to facilitate clinical trial development and academic growth.

The successful candidate will join the faculty of Rutgers Robert Wood Johnson Medical School on the Clinical Scholar track, with approximately 0.6 clinical FTE dedicated to supporting both academic and clinical priorities. Clinical practice will be located in the Jack & Sheryl Morris Cancer Center, a state-of-the-art, freestanding cancer hospital designed to advance cancer research and patient care through multidisciplinary collaboration.

Candidate Qualifications

See all our open faculty positions here!

Position Status Full Time Posting Number 26FA0770 Posting Open Date 03/06/2026 Posting Close Date 09/30/2026

Qualifications

Minimum Education and Experience

Qualified candidates must have:

• MD or equivalent degree
• Completed or completing an accredited Hematology/Oncology fellowship program
• Board Certified or Board Eligible in Medical Oncology and/or Hematology
• Eligible for or currently holding a New Jersey medical license
• Demonstrated interest and experience in clinical research

Certifications/Licenses Required Knowledge, Skills, and Abilities Preferred Qualifications

Experience in Phase I or early-phase clinical trials is preferred. Candidates at mid-senior level with experience and expertise in conducting and leading clinical research.

Equipment Utilized Physical Demands and Work Environment Overview

RBHS

New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University-New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.

Rutgers Robert Wood Johnson Medical School

As one of the nation's comprehensive medical schools, Rutgers Robert Wood Johnson Medical School (RWJMS) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school's principal affiliate, they comprise New Jersey's premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below. The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013.

Rutgers Cancer Institute

As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, in partnership with RWJBarnabas Health, is a leader in cancer research, treatment, prevention, and education. Rutgers Cancer Institute offers world-class cancer care, providing patients with the most advanced treatment options through an integrated cancer care network, including clinical trials, immunotherapy, precision medicine, complex surgical procedures, and sophisticated radiation therapy techniques. Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, are one of only two programs in the state to offer blood and marrow transplantations and CAR T-cell therapy. It also houses the state's only hospital-based proton therapy center. Rutgers Cancer Institute is a cornerstone of New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS).

Construction is currently underway for a new $750 million state-of-the-art Cancer Center adjacent to the current Rutgers Cancer Institute facility and Robert Wood Johnson University Hospital. The 510,000 square foot Jack and Sheryl Morris Cancer Center will be the state's first free-standing cancer hospital. It will feature outpatient and inpatient clinical space-including 84 infusion bays, 74 exam rooms, and 96 inpatient beds. This is in addition to state-of-the-art laboratories where critical scientific investigation will be amplified, enabling physician-scientists to translate findings directly to patients. The Jack and Sheryl Morris Cancer Center will also have the capacity to offer wellness and education resources all in one location. Learn more about this incredible facility at www.cinj.org/jackandsherylmorriscancercenter.

Rutgers Cancer Institute is home to nearly 250 internationally recognized physicians and researchers. The long-standing relationship with their NCI Research Consortium Partner Princeton University was recently leveraged to establish the Ludwig Cancer Research Princeton Branch with several faculty as founding members and leaders of the Branch. Their work on cancer metabolism, not only through the new Ludwig Branch but also through the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, will accelerate and translate laboratory discoveries into clinical treatments through more effective and efficiently designed clinical trials.

The Rutgers Cancer Institute's Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence is an institute at the intersection of oncologic immunology and metabolism that seeks to increase research that leads to new therapies for patients; develop cutting-edge facilities to test new interventions; and facilitate commercial and university collaborations. This includes discovery and production of novel cell therapy constructs via an institutional good manufactory practices (GMP) facility. Visit Center of Excellence in Cancer Immunology and Metabolism.

Statement

Rutgers Cancer Institute, the state's only NCI-designated Comprehensive Cancer Center and RWJBarnabas Health, the state's largest health care delivery system partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Through the above mentioned partnership and an academic appointment at Rutgers, The State University of New Jersey, unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.

Mission

To accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and compassionate patient care; to provide evidence-based and culturally informed education to physicians, nurses, researchers, staff, and the community; and to achieve cancer health equity in our state through outreach to and engagement of our extraordinarily diverse communities

Vision

Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused research worldwide and reduce the burden of cancer in our catchment area. By engaging with and empowering our exceptionally diverse populations, and addressing their questions and fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology care each person deserves.

Core Values

• Curiosity and Discovery: encouraging an environment of continuous inquiry, creativity, and innovation to generate new knowledge
• Integrity: earning the trust of those we serve and each other through honesty, transparency, accountability, and continuous reflection
• Collaboration: approaching all opportunities with an understanding that together we are better and can achieve more; promoting and maintaining an environment of teamwork and shared knowledge
• Cultivating Diversity: making conscientious efforts in all we do to ensure that our leadership, scientists, clinicians, supporting staff, and trainees reflect the rich diversity of the state of New Jersey and the patient populations and communities we serve
• Respect and Caring: consistently demonstrating caring, compassion, and respect through our words and actions
• Perseverance: maintaining an unwavering commitment to our mission; embracing change, overcoming obstacles, and creating and recreating the path to achieve our goals

Posting Details

Special Instructions to Applicants

Applicants should submit a CV, a cover letter detailing how the candidate's work will contribute to the Rutgers Cancer Institute Mission, and list 3 references with contact information or upload reference letters.

Quick Link to Posting https://jobs.rutgers.edu/postings/280825 Campus Rutgers Biomedical and Health Sciences (RBHS) Home Location Campus Downtown New Brunswick City New Brunswick State NJ Location Details

Pre-employment Screenings

All offers of employment are contingent upon successful completion of all pre-employment screenings.

Immunization Requirements

Under Policy 100.3.1 Immunization Policy for Covered Individuals, if employment will commence during Flu Season, Rutgers University may require certain prospective employees to provide proof that they are vaccinated against Seasonal Influenza for the current Flu Season, unless the University has granted the individual a medical or religious exemption. Additional infection control and safety policies may apply. Prospective employees should speak with their hiring manager to determine which policies apply to the role or position for which they are applying. Failure to provide proof of vaccination for any required vaccines or obtain a medical or religious exemption from the University will result in rescission of a candidate's offer of employment or disciplinary action up to and including termination.

Equal Employment Opportunity Statement

It is university policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law. As an institution, we encourage all qualified applicants to apply. For additional information please see the Non-Discrimination Statement at the following web address: http://uhr.rutgers.edu/non-discrimination-statement

Posting Specific Questions

Required fields are indicated with an asterisk (*).

Applicant Documents

Required Documents

• Cover Letter/Letter of Application
• Curriculum Vitae

Optional Documents

• Other Document
• List of Professional References (contact Info)
• Research Statement
• Other Documents (2)
• Other Documents (3)